Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice

Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice

Stressors activate the hypothalamic-pituitary-adrenal (HPA) axis and immune system eliciting changes in cognitive function, mood and anxiety. An important link between stress and altered behavior is stimulation of the Kynurenine Pathway which generates neuroactive and immunomodulatory kynurenines. T...

Full description

Bibliographic Details
Main Authors:	Carlos R. Dostal, Megan Carson Sulzer, Keith W. Kelley, Gregory G. Freund, Robert H. McCusker
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Neurobiology of Stress
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352289516300492

Similar Items

An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases
by: Li Bo, et al.
Published: (2018-06-01)

The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors
by: Amy B. Heimberger, et al.
Published: (2023-01-01)

Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
by: Wei Wu, et al.
Published: (2013-01-01)

Immunomodulatory factors galectin-9 and interferon-gamma synergize to induce expression of rate-limiting enzymes of the Kynurenine Pathway in the mouse hippocampus
by: Alexandra K Brooks, et al.
Published: (2016-10-01)

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
by: Ewelina Rojewska, et al.
Published: (2018-07-01)

Indoleamine-2,3-Dioxygenase Mediates Emotional Deficits by the Kynurenine/Tryptophan Pathway in the Ethanol Addiction/Withdrawal Mouse Model
by: Xi Jiang, et al.
Published: (2020-02-01)

The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
by: Knut A. Hestad, et al.
Published: (2017-10-01)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
by: Tamera D. Hughes, et al.
Published: (2022-01-01)

Kynurenine acid - metabolism and regulation of kynurenine pathway
by: Piotr Kozłowski, et al.
Published: (2017-07-01)

Kynurenine acid - metabolism and regulation of kynurenine pathway
by: Piotr Kozłowski, et al.
Published: (2017-07-01)

Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells
by: Hani Oweira, et al.
Published: (2022-08-01)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
by: Robert S. Phillips, et al.
Published: (2019-02-01)

Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice
by: Dantzer Robert, et al.
Published: (2011-02-01)

Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
by: Katrien Skorobogatov, et al.
Published: (2023-02-01)

Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production
by: Michele Bellucci, et al.
Published: (2021-05-01)

Indoleamine 2,3‐dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival
by: Sameh Souissi, et al.
Published: (2022-09-01)

Interleukin‐6 promotes skeletal muscle catabolism by activating tryptophan–indoleamine 2,3‐dioxygenase 1–kynurenine pathway during intra‐abdominal sepsis
by: Tingbin Xie, et al.
Published: (2023-04-01)

Kynurenine Pathway in Respiratory Diseases
by: Guillaume Pamart, et al.
Published: (2024-03-01)

Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide
by: Park Sook-Eun, et al.
Published: (2011-12-01)

Kynurenine pathway metabolites in Alzheimer's disease.
by: Giil, L, et al.
Published: (2017)

Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
by: Shivani Krishnamurthy, et al.
Published: (2021-10-01)

The kynurenine pathway in HIV, frailty and inflammaging
by: Shabiha Sultana, et al.
Published: (2023-09-01)

The kynurenine pathway of tryptophan catabolism and schizophrenia
by: Marković Miloš, et al.
Published: (2023-01-01)

Kynurenine pathway in Parkinson's disease—An update
by: Dhivya Venkatesan, et al.
Published: (2020-12-01)

Kynurenine pathway metabolism and neuroinflammatory disease
by: Nady Braidy, et al.
Published: (2017-01-01)

RNA Interference-Mediated Knockdown of Tryptophan 2,3-Dioxygenase and Kynurenine-3-Monooxygenase in Monochamus Alternatus: Implications for Insect Control
by: Minghui Zhang, et al.
Published: (2023-06-01)

Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
by: Hannah Jonescheit, et al.
Published: (2020-05-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
by: Lisa A. Wetzel, et al.
Published: (2020-08-01)

The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis
by: Charlise Basson, et al.
Published: (2023-09-01)

APOE Polymorphism Is Associated with Changes in the Kynurenine Pathway
by: Per G. Farup, et al.
Published: (2023-10-01)

The kynurenine pathway in traumatic brain injuries and concussion
by: Mona Dehhaghi, et al.
Published: (2023-06-01)

Kynurenine Pathway in Psoriasis—a Promising Link?
by: A. Stepaniuk, et al.
Published: (2023-06-01)

Involvement of the kynurenine pathway in human glioma pathophysiology.
by: Seray Adams, et al.
Published: (2014-01-01)

An exploratory study of neopterin and kynurenine pathway in pterygium
by: Kilicarslan Bilge, et al.
Published: (2019-08-01)

Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity
by: Ananda Staats Pires, et al.
Published: (2020-06-01)

Glial Tissue Mechanics and Mechanosensing by Glial Cells
by: Katarzyna Pogoda, et al.
Published: (2018-02-01)

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
by: Schimmelmann Benno G, et al.
Published: (2010-06-01)

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication
by: Schwarz Markus J, et al.
Published: (2010-05-01)

Indoleamine 2,3-dioxygenase mediates the therapeutic effects of adipose-derived stromal/stem cells in experimental periodontitis by modulating macrophages through the kynurenine-AhR-NRF2 pathway
by: Hanyue Li, et al.
Published: (2022-12-01)

Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice
by: Alexandre G. Maganin, et al.
Published: (2022-12-01)